Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 991K
2: EX-23.1 Consent of Expert or Counsel HTML 22K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 27K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 27K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 26K
11: R1 Cover HTML 87K
12: R2 Audit Information HTML 27K
13: R3 Consolidated Balance Sheets HTML 121K
14: R4 Consolidated Balance Sheets (Parenthetical) HTML 38K
15: R5 Consolidated Statements of Operations HTML 92K
16: R6 Consolidated Statements of Comprehensive Loss HTML 48K
17: R7 Consolidated Statements of Cash Flows HTML 110K
18: R8 Consolidated Statements of Convertible Preferred HTML 109K
Stock and Stockholders' Equity
19: R9 Consolidated Statements of Series B Convertible HTML 24K
Preferred Stock and Stockholders' Equity (Deficit)
(Parenthetical)
20: R10 Nature of Business and Basis of Presentation HTML 31K
21: R11 Summary of Significant Accounting Policies HTML 67K
22: R12 Investments HTML 42K
23: R13 Fair Value Measurements HTML 61K
24: R14 Property and Equipment, Net HTML 34K
25: R15 Accrued Expenses HTML 32K
26: R16 Commitments and Contingencies HTML 33K
27: R17 License Agreements HTML 28K
28: R18 Capital Stock and Warrants HTML 57K
29: R19 Stock-Based Compensation HTML 57K
30: R20 Leases HTML 47K
31: R21 Cares Act Loan HTML 28K
32: R22 Income Taxes HTML 83K
33: R23 Employee Benefits HTML 28K
34: R24 Government Research Grants HTML 26K
35: R25 Geographic Information HTML 40K
36: R26 Related Party Transaction HTML 26K
37: R27 Summary of Significant Accounting Policies HTML 107K
(Policies)
38: R28 Summary of Significant Accounting Policies HTML 54K
(Tables)
39: R29 Investments (Tables) HTML 41K
40: R30 Fair Value Measurements (Tables) HTML 59K
41: R31 Property and Equipment, Net (Tables) HTML 37K
42: R32 Accrued Expenses (Tables) HTML 32K
43: R33 Capital Stock and Warrants (Tables) HTML 50K
44: R34 Stock-Based Compensation (Tables) HTML 55K
45: R35 Leases (Tables) HTML 44K
46: R36 Income Taxes (Tables) HTML 82K
47: R37 Geographic Information (Tables) HTML 36K
48: R38 Nature of Business and Basis of Presentation HTML 25K
(Details)
49: R39 Summary of Significant Accounting Policies - HTML 32K
Reconciliation of Cash, Cash Equivalents and
Restricted Cash (Details)
50: R40 Summary of Significant Accounting Policies - HTML 29K
Estimated Useful Lives (Details)
51: R41 Summary of Significant Accounting Policies - HTML 32K
Antidilutive Common Stock Excluded From
Calculation of Dilutive Shares (Details)
52: R42 Summary of Significant Accounting Policies - HTML 48K
Narrative (Details)
53: R43 Investments (Details) HTML 37K
54: R44 Fair Value Measurements - Narrative (Details) HTML 29K
55: R45 Fair Value Measurements - Assets and Liabilities HTML 51K
Measured at Fair Value on a Recurring Basis
(Details)
56: R46 Fair Value Measurements - Level 3 Rollforward of HTML 29K
Warrant Liability (Details)
57: R47 Property and Equipment, Net (Details) HTML 42K
58: R48 Accrued Expenses (Details) HTML 36K
59: R49 Commitments and Contingencies (Details) HTML 30K
60: R50 License Agreements (Details) HTML 23K
61: R51 Capital Stock and Warrants - Narrative (Details) HTML 92K
62: R52 Capital Stock and Warrants - Schedule Of Warrants HTML 44K
Issuance (Details)
63: R53 Capital Stock and Warrants - Schedule of Common HTML 30K
Stock Reserved For Future Issuance (Details)
64: R54 Stock-Based Compensation - Narrative (Details) HTML 100K
65: R55 Stock-Based Compensation - Stock Option Activity HTML 79K
(Details)
66: R56 Stock-Based Compensation - Assumptions Used for HTML 41K
Fair Value of Stock Options (Details)
67: R57 Stock-Based Compensation - Restricted Stock Units HTML 34K
(RSUs) (Details)
68: R58 Leases - Maturity Analysis of Lease Liabilities HTML 43K
(Details)
69: R59 Leases - Quantitative Disclosure of Lease Costs HTML 37K
(Details)
70: R60 Leases - Narrative (Details) HTML 40K
71: R61 Cares Act Loan (Details) HTML 23K
72: R62 Income Taxes (Details) HTML 123K
73: R63 Income Taxes - Details Textual (Details) HTML 42K
74: R64 Employee Benefits (Details) HTML 29K
75: R65 Government Research Grants (Details) HTML 47K
76: R66 Geographic Information (Details) HTML 39K
77: R67 Geographic Information - Narrative (Details) HTML 39K
78: R68 Related Party Transaction (Details) HTML 30K
81: XML IDEA XML File -- Filing Summary XML 149K
79: XML XBRL Instance -- yten-20211231_htm XML 1.49M
80: EXCEL IDEA Workbook of Financial Reports XLSX 99K
7: EX-101.CAL XBRL Calculations -- yten-20211231_cal XML 204K
8: EX-101.DEF XBRL Definitions -- yten-20211231_def XML 570K
9: EX-101.LAB XBRL Labels -- yten-20211231_lab XML 1.65M
10: EX-101.PRE XBRL Presentations -- yten-20211231_pre XML 976K
6: EX-101.SCH XBRL Schema -- yten-20211231 XSD 151K
82: JSON XBRL Instance as JSON Data -- MetaLinks 419± 607K
83: ZIP XBRL Zipped Folder -- 0001121702-22-000008-xbrl Zip 872K
1. I have reviewed this annual report on Form 10-K of Yield10 Bioscience, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the
case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
